Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

New York, Jan 20, 2026, 18:51 EST — After-hours

  • Lam Research closed the regular session down 0.25%, with little movement in after-hours trading
  • Tech shares dipped after renewed tariff warnings rattled the market, stirring volatility among chipmakers
  • UBS lifted its price target for Lam, as investors look ahead to the Jan. 28 earnings report for guidance

Lam Research Corp shares slipped roughly 0.2% in after-hours trading Tuesday, holding close to $222 following a choppy session that ended with little change. 1

The chip-equipment maker faces a crucial week, with political tensions shaping risk appetite and its earnings report due in eight days. Lam has announced its quarterly financial conference call will take place on Jan. 28. 2

The date is crucial since Lam provides wafer fabrication equipment—key tools for chip production—and investors often interpret its outlook as a gauge of chipmakers’ appetite for new plants and upgrades.

Wall Street stumbled Tuesday, hit by concerns over U.S. President Donald Trump’s tariff threats targeting Europe. The news spooked investors, driving them away from riskier assets and dragging down tech-focused indexes. 3

Trump announced that an extra 10% tariff will kick in on Feb. 1 for products from eight European nations, linking the measure to his bid for U.S. control over Greenland. 4

Lam’s decline was relatively mild compared to others in the sector. Applied Materials slid 2.7%, while inspection-tool specialist KLA tumbled 5.2% during the regular session, MarketWatch data shows. 5

UBS gave bulls a boost, lifting its price target on Lam to $255 from $200 while maintaining a “Buy” rating. The firm cited ongoing checks that suggest a solid Q2 performance and an optimistic guidance outlook. 6

Shares swung between roughly $217.61 and $226.15 on Tuesday, finally closing close to $222. 1

A lot can go sideways. A prolonged trade dispute might freeze budgets and throw supply chains into chaos, while even a robust chip cycle can stumble if customers delay their orders. “Geopolitical tensions have dented sentiment and cooled early-year exuberance,” said Nuveen strategist Laura Cooper. 7

Investors are keeping an eye on whether the tariff dispute will escalate into wider policy battles, as markets monitor the legal and political fallout from Trump’s trade moves. 8

Lam’s earnings report and conference call on Jan. 28 will be key. Investors will be listening closely for any shifts in management’s outlook on demand, delivery schedules, and customer spending. This could reshape forecasts for the stock. 2

Stock Market Today

Constellation Energy stock jumps nearly 6% — what to watch next week for CEG

Constellation Energy stock jumps nearly 6% — what to watch next week for CEG

7 February 2026
Constellation Energy shares jumped 5.8% to $261.42 Friday, snapping a seven-day losing streak amid heavy trading in short-dated $260 call options. The stock remains 37% below its 52-week high. Attention is turning to mid-February earnings and U.S. nuclear policy changes after the NRC announced plans to speed reactor licensing.
AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

7 February 2026
AST SpaceMobile shares jumped 9.1% to $101.79 Friday after a volatile week, with 15.9 million shares traded. AT&T said it will use Amazon Leo’s satellite network to reach business customers outside its terrestrial footprint but stated this will not affect its partnership with AST. A new 2x short ETF tied to ASTS, ticker ASTN, began trading on Cboe. AST’s next “BlueBird 7” satellite launch is set for late February on Blue Origin’s New Glenn.
Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug
Previous Story

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos
Next Story

Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos

Go toTop